Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Management
View:
Post by Bucknelly21 on Aug 18, 2021 7:25pm

Management

Management

Of all metrics mentioned, "Management" is most imperative for successful investing. Perhaps, the quality of your management isn't obvious in good times. Nevertheless, you can see how essential great management is in bad times. In my view, the management's pedigree is important but their attitude is most crucial.

If the management jumps ship at the first sign of trouble, you want to steer away from such a company. You also want management that is transparent and shareholder-friendly. In other words, that management should pick up the phone to talk to you about their stock.

Most importantly, you want to see a management that delivers what they promised. For Madrigal, the President and CEO is also an MD (i.e., Dr. Paul Friedman) which gives him added advantages in the pharmaceuticals niche. That's because he is familiar with the prescribing pattern. In light of recent developments, Dr. Friedman enthused,

We are pleased with the substantial progress the Company made in 2020, particularly in light of the significant challenges resulting from the COVID-19 pandemic. We completed enrollment in the Company’s Phase 3 MAESTRO-NAFLD-1 trial in less than 12 months, and we also made significant progress in enrollment of our Phase 3 MAESTRO-NASH trial. We advanced the development of Madrigal’s commercial capabilities in 2020, with Remy Sukhija joining the Company as Senior Vice President and Chief Commercial Officer. Remy and his team have embarked on detailed analyses of the market opportunity for resmetirom as we continue to execute our Phase 3 clinical programs.

Comment by scarlet1967 on Aug 19, 2021 8:56am
The transparency quoted below to me is the key to earn the trust of investors something which haven't been the case in many occasions for this company another thing is communication with capital market which hasn't been that grear either. Although I have to say they are improving in both areas there is still some shortcomings. For instance why should we get the notice re the NASH webinar ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities